Skip to content

Clinical trials

Phase 1 Major Depressive Disorder trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 1 Country / region: Canada Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20071
20101
20141
20151
20161
20181
20211
20222
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting3
Active, not recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre for Addiction and Mental Health4
Sunnybrook Health Sciences Centre3
University of Calgary2
BlackThorn Therapeutics, Inc.1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
Mount Sinai Hospital, Canada1
Verinder Sharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder13
Anorexia Nervosa1
Bipolar Disorder1
Dementia1
Depression, Postpartum1
Depressive Disorder1
Depressive Disorder, Treatment-Resistant1
Mental Disorders1
Mood Disorders1
Obsessive-Compulsive Disorder1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.